Anteris Technologies company info

What does Anteris Technologies do?
Anteris Technologies (ASX:AVR) is a structural heart company focused on delivering clinically superior solutions that create life-changing outcomes for patients. Anteris Technologies has developed DurAVR™ THV, which is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue. It’s designed to mimic the performance of a pre-disease human aortic valve. It’s also created ADAPT®, which is a patented anti-calcification tissue technology. ADAPT® tissue has been used clinically for over 10 years and distributed for use in over 50,000 patients worldwide.
Anteris Technologies company media
Company Snapshot

Is Anteris Technologies a public or private company?

key
Ownership
Public

How many people does Anteris Technologies employ?

people
Employees
88

What sector is Anteris Technologies in?

pie chart
Sector
Health Care

Where is the head office for Anteris Technologies?

location pin
Head Office
Queensland, Australia

What year was Anteris Technologies founded?

founded flag
Year Founded
1999
What does Anteris Technologies specialise in?
/Medtech /Medical /Healthcare /Heart /Treatment /Hospital

What are the products and/or services of Anteris Technologies?

Overview of Anteris Technologies offerings
DurAVR™: DurAVR™ is a next-generation aortic valve replacement system that is currently in clinical trials. DurAVR™ is designed to provide patients with a more durable and longer-lasting valve replacement option.
ADAPT™: ADAPT™ is a proprietary tissue platform that is used to manufacture Anteris' products. ADAPT™ is designed to create tissues that are more biocompatible and durable than traditional tissues.
ComASUR™ Delivery System provides controlled deployment and accurate placement of the DurAVR™ THV valve, designed to achieve precise alignment with the heart’s native commissures to achieve ideal valve positioning.

Who is in the executive team of Anteris Technologies?

Anteris Technologies leadership team
  • Mr. Wayne G. Paterson
    Mr. Wayne G. Paterson
    CEO, MD & Executive Director
  • Mr. Matthew  McDonnell
    Mr. Matthew McDonnell
    Chief Financial Officer
  • Mr. David St. Denis
    Mr. David St. Denis
    Chief Operating Officer
  • Dejan  Toracki
    Dejan Toracki
    Corporate Development Director
  • Dr. Chris  Meduri M.D., M.P.H.
    Dr. Chris Meduri M.D., M.P.H.
    Chief Medical Officer & Member of Medical Advisory Board
  • Mr. Stephen  Denaro
    Mr. Stephen Denaro
    Independent Non-Executive Director & Company Secretary